Boston Scientific said Monday it will pay medical device rival Johnson & Johnson $1.73 billion to settle several seven-year-old patent disputes over drug-coated stents. Boston Scientific will pay Johnson & Johnson's Cordis unit $1 billion this week and $725 million next January. The settlement resolves three patent disputes dating back to 2003, and avoids jury trials that were scheduled to begin later this month.
February 02, 2010 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Boston Scientific said Monday it will pay medical device rival Johnson and Johnson $1.73 billion to settle several seven-year-old patent disputes over drug-coated stents.
Boston Scientific will pay Johnson & Johnson’s Cordis unit $1 billion this week and $725 million next January. The settlement resolves three patent disputes dating back to 2003, and avoids jury trials that were scheduled to begin later this month.
Presented by BigVoodoo
Celebrating achievement, excellence, and innovation in the legal profession in the UK.
Join the industry's top owners, investors, developers, brokers and financiers for the real estate healthcare event of the year!
This event shines a spotlight on how individuals and firms are changing the investment advisory industry where it matters most.
Description: Fox Rothschild has an opening in the New York office for a Real Estate Litigation Associate with three to six years of commerci...
Downtown NY property and casualty defense law firm seeks a Litigation Associate with 3+ years' experience to become a part of our team! You ...
Description: Fox Rothschild has an opening in the New York office for a Counsel in our renowned Labor & Employment Department, working w...
